MITO 42 - TO CARE
Time tO last ChemotherApy and death in ovaRian cancEr patients: TO CARE/MITO 42 study, a retrospective analysis of italian MITO centers
COORDINAMENTO
PRINCIPAL
INVESTIGATOR
Giorgio Valabrega
SUB
INVESTIGATOR
Giulia Scotto